Heparin as adjuvant anticancer therapy in colorectal cancer?;Heparin som adjuverende anticancerterapi ved kolorektal cancer?

Ugeskrift for Laeger

Volumn 165, Issue 18, 2003, Pages 1866-1867

  Lykke, Jakob ^a   Rasmussen, Hans Morten Schnack ^b   Nielsen, Hans Jørgen ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; FLUOROURACIL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANGIOGENESIS; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COLORECTAL CANCER; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HEMOSTASIS; HUMAN; SHORT SURVEY; ADJUVANT CHEMOTHERAPY; ARTICLE; COLORECTAL TUMOR;

ANTICOAGULANTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS;

EID: 0037974838     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Wojtukiewicz MZ, Sierko E, Klement P et al. The hemostatic system and angiogenesis in malignancy. Neoplasia 2001;3:371-84.
2. Hejna M, Raderer M, Zielinski CC. Inhibition of metastases by anticoagulants. J Natl Cancer Inst 1999;91:22-36.
3. Hettiarachchi RJ, Smorenburg SM, Ginsberg J et al. Do heparins do more than just treat thrombosis? Thromb Haemost 1999;82:947-52.
4. Ornstein DL, Zacharski LR. The use of heparin for treating human malignancies. Haemostasis 1999;29(suppl 1):48-60,
5. Kakkar AK, Hedges AR, Willamson RCN et al. Perioperative heparin therapy inhibits late death from metastatic cancer. Int J Oncology 1995;6:885-8.
6. Torngren S, Rieger A. The influence of heparin and curable resection on the survival of colorectal cancer. Acta Chir Scand 1983;149:427-9.
7. Kingston RD, Fielding JW, Palmer MK. Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer? Int J Colorectal Dis 1993;8:111-5.
8. Iversen LH, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 2002;87:402-8.
9. Nielsen HJ, Pappot H, Christensen IJ et al, Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer. BMJ 1998;316:829-30.
10. Svendsen MN, Werther K, Nielsen HJ et al, VEGF and tumour angiogenesis, Scand J Gastroenterol 2002;37:373-9.